½ÃÀ庸°í¼­
»óǰÄÚµå
1587548

ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Ä¡·á ºÐ¾ßº°, ¿ëµµº°, ÀÓÇöõÆ®º°, ±â¼úº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Medical Device Validation & Verification Market Size, Share & Trends Analysis Report By Therapeutic Area (Cardiovascular, Dermatology), By Application, By Implants, By Technology, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå ±Ô¸ð´Â 2025-2030³â µ¿¾È ¿¬Æò±Õ 8.8%ÀÇ CAGR·Î È®´ëµÇ¾î 2030³â¿¡´Â 17¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°í±Þ ¹× °íǰÁú ÀÇ·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¦Ç° ¼³°è ¹× ¿£Áö´Ï¾î¸µÀÇ º¹À⼺ Áõ°¡·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ºÐ¾ßÀÇ ±Þ¼ÓÇÑ ±â¼ú Çõ½ÅÀº È®ÀÎ ¹× °ËÁõ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ±â¾÷µéÀÌ »õ·Î¿î ±â¼ú°ú ¼ÒÇÁÆ®¿þ¾î ¾ÖÇø®ÄÉÀ̼ÇÀ» Á¦Ç°¿¡ ÅëÇÕÇØ¾ß ÇÒ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. Á¦Ç°ÀÇ º¹À⼺ Áõ°¡, »õ·Î¿î À¯ÇüÀÇ Àç·áÀÇ °¡¿ë¼º, Á¦Ç° °áÇÔÀÇ ³ôÀº À§Ç輺 µîÀº È®ÀÎ ¹× °ËÁõ ¼­ºñ½ºÀÇ Çʿ伺À» ³ôÀÌ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

ºÏ¹Ì´Â 2019³â Àüü ¸ÅÃâÀÇ 44.88%¸¦ Â÷ÁöÇϸç Àü ¼¼°è ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. È®ÀÎ ¹× °ËÁõÀ» Æ÷ÇÔÇÑ È¿À²ÀûÀÎ ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ÀÇ·á±â±â Á¦Á¶°¡ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â °ÍÀÌ ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ÀÇ ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æµµ ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È 12.1%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̴ ƯÈ÷ ÀϺ», Áß±¹, Àεµ¿¡¼­ ÁøÀÔ ±âȸ Áõ°¡, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© °³¼±, ÀÇ·á±â±â ±â¾÷ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.

ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Àü ¼¼°èÀûÀ¸·Î ¾Ï ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áø´Ü, Ä¡·á ¹× ¸ð´ÏÅ͸µÀ» À§ÇÑ Ã·´Ü ÀÇ·á±â±â°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.
  • Áø´Ü ºÎ¹®Àº 2024³â 44.0%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ´Â Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¿¹¹æ ÀÇÇÐÀ¸·ÎÀÇ ÀüȯÀ¸·Î ÀÎÇØ ´õ ³ªÀº Ä¡·á °á°ú¿Í ºñ¿ë Àý°¨À» À§ÇØ Á¶±â Áø´Ü¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.
  • Ä¡·á ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 9.0%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´ ¹× ½ÉÇ÷°üÁúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í È¿°úÀûÀÎ °ü¸®¸¦ À§ÇØ ¾à¹°Àü´Þ ½Ã½ºÅÛ ¹× ÁÖÀÔ ÆßÇÁ¿Í °°Àº °ËÁõµÈ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
  • ºÏ¹Ì ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀåÀº 2024³â 45.2%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå : Ä¡·á ºÐ¾ß ºñÁî´Ï½º ºÐ¼®

  • Ä¡·á ºÐ¾ß ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • Ä¡·á ºÐ¾ß ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, Ä¡·á ºÐ¾ßº°, 2018-2030³â
  • ½ÉÇ÷°ü
  • ÇǺΰú
  • Á¤Çü¿Ü°ú
  • ½ÅÀåÇÐ
  • È£Èí±â
  • ½Å°æÇÐ
  • Á¾¾çÇÐ
  • À̺ñÀÎÈİú
  • ±âŸ

Á¦5Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå : ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • Áø´Ü
  • Ä¡·á
  • ÀÓÇöõÆ®

Á¦6Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå : ÀÓÇöõÆ® ºñÁî´Ï½º ºÐ¼®

  • ÀÓÇöõÆ® ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ÀÓÇöõÆ® ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ÀÓÇöõÆ®º°, 2018-2030³â
  • ´Éµ¿Çü À̽ÄÇü ÀÇ·á±â±â
  • ÀÇ·á ÀÓÇöõÆ®

Á¦7Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå : ±â¼ú ºñÁî´Ï½º ºÐ¼®

  • ±â¼ú ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • ±â¼ú ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ±â¼úº°, 2018-2030³â
  • ±â°è °Ë»ç
  • »ý¹°ÇÐÀû °Ë»ç
  • ÀüÀÚ °£¼·/ÀüÀÚÆÄ ÀûÇÕ¼º
  • Àü±â ¾ÈÀü °Ë»ç

Á¦8Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå : Ä¡·á ºÐ¾ßº° Áö¿ª, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦9Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå : ¿ëµµº° Áö¿ª, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦10Àå ÀÇ·á±â±â È®ÀÎ ¹× °ËÁõ ½ÃÀå : ÀÓÇöõÆ®º° Áö¿ª, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
ksm 24.11.25

Medical Device Validation & Verification Market Growth & Trends:

The global medical device validation and verification market size is expected to reach USD 1.71 billion by 2030, expanding at a CAGR of 8.8% from 2025 to 2030, according to a new report by Grand View Research, Inc.

Increase in demand for advanced and quality medical products and rising complexity with respect to product designing and engineering are anticipated to boost market growth. Rapid innovations in healthcare have increased the need for companies to incorporate new technologies and software applications in their products to meet the demand for validation and verification. Increase in product complexity, availability of newer types of material, and high risk of product failures are some of the key factors increasing the need for validation and verification services.

North America dominated the global medical device validation and verification market, accounting for 44.88% share of the overall revenue in 2019. Rapid growth in manufacturing of medical devices to meet high demand for efficient healthcare services, including validation and verification, is one of the major factors contributing to the regional market growth. In addition, stringent regulatory environment in U.S. is fueling market growth in the region.

Asia Pacific is anticipated to expand at a CAGR of 12.1% during the forecast period. This can be attributed to increased opportunities for players, especially in Japan, China, and India, improved regulatory framework, and increase in the number of medical devices companies.

Medical Device Validation & Verification Market Report Highlights:

  • The oncology segment dominated the market, with a revenue share of 26.5% in 2024, driven by the rising incidence of cancer globally, demanding advanced medical devices for diagnosis, treatment, and monitoring.
  • The diagnostics segment dominated the market with the largest revenue share of 44.0% in 2024, driven by increasing demand for early disease detection and a shift towards preventive healthcare, emphasizing early diagnosis for better treatment outcomes and lower costs.
  • The therapeutic segment is projected to grow at a CAGR of 9.0% over the forecast period. It is fueled by the rising prevalence of chronic diseases like diabetes and cardiovascular conditions, demanding validated devices such as drug delivery systems and infusion pumps for effective management.
  • North America medical device validation & verification market dominated the global market with a revenue share of 45.2% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapeutic Area
    • 1.2.2. Application
    • 1.2.3. Implants
    • 1.2.4. Technology
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Medical Device Validation and Verification Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Medical Device Validation and Verification Market: Therapeutic Area Business Analysis

  • 4.1. Therapeutic Area Market Share, 2024 & 2030
  • 4.2. Therapeutic Area Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Billion)
  • 4.4. Cardiovascular
    • 4.4.1. Cardiovascular Market, 2018 - 2030 (USD Billion)
  • 4.5. Dermatology
    • 4.5.1. Dermatology Market, 2018 - 2030 (USD Billion)
  • 4.6. Orthopedics
    • 4.6.1. Orthopedics Market, 2018 - 2030 (USD Billion)
  • 4.7. Nephrology
    • 4.7.1. Nephrology Market, 2018 - 2030 (USD Billion)
  • 4.8. Respiratory
    • 4.8.1. Respiratory Market, 2018 - 2030 (USD Billion)
  • 4.9. Neurology
    • 4.9.1. Neurology Market, 2018 - 2030 (USD Billion)
  • 4.10. Oncology
    • 4.10.1. Oncology Market, 2018 - 2030 (USD Billion)
  • 4.11. ENT
    • 4.11.1. ENT Market, 2018 - 2030 (USD Billion)
  • 4.12. Others
    • 4.12.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Medical Device Validation and Verification Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Diagnostics
    • 5.4.1. Diagnostics Market, 2018 - 2030 (USD Billion)
  • 5.5. Therapeutic
    • 5.5.1. Therapeutic Market, 2018 - 2030 (USD Billion)
  • 5.6. Implants
    • 5.6.1. Implants Market, 2018 - 2030 (USD Billion)

Chapter 6. Medical Device Validation and Verification Market: Implants Business Analysis

  • 6.1. Implants Market Share, 2024 & 2030
  • 6.2. Implants Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Implants, 2018 to 2030 (USD Billion)
  • 6.4. Active Implantable Medical Device
    • 6.4.1. Active Implantable Medical Device Market, 2018 - 2030 (USD Billion)
  • 6.5. Medical Implants
    • 6.5.1. Medical Implants Market, 2018 - 2030 (USD Billion)

Chapter 7. Medical Device Validation and Verification Market: Technology Business Analysis

  • 7.1. Technology Market Share, 2024 & 2030
  • 7.2. Technology Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
  • 7.4. Mechanical Testing
    • 7.4.1. Mechanical Testing Market, 2018 - 2030 (USD Billion)
  • 7.5. Biological
    • 7.5.1. Biological Market, 2018 - 2030 (USD Billion)
  • 7.6. EMI/EMC
    • 7.6.1. EMI/EMC Market, 2018 - 2030 (USD Billion)
  • 7.7. Electrical Safety Testing
    • 7.7.1. Electrical Safety Testing Market, 2018 - 2030 (USD Billion)

Chapter 8. Medical Device Validation and Verification Market: Regional Estimates & Trend Analysis by Therapeutic Area

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.4. North America
    • 8.4.1. North America Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.5. Europe
    • 8.5.1. Europe Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Latin America Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8. MEA
    • 8.8.1. MEA Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Medical Device Validation and Verification Market: Regional Estimates & Trend Analysis by Application

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. U.S. Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Canada Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. Mexico Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.5. Europe
    • 9.5.1. Europe Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. UK Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Germany Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. France Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Competitive Insights
      • 9.5.5.4. Italy Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Competitive Insights
      • 9.5.6.4. Spain Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.5.7. Norway
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Competitive Insights
      • 9.5.7.4. Norway Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.5.8. Denmark
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Competitive Insights
      • 9.5.8.4. Denmark Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.5.9. Sweden
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Competitive Insights
      • 9.5.9.4. Sweden Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Japan Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. China Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. India Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.6.5. South Korea
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. South Korea Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.6.6. Australia
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. Competitive Insights
      • 9.6.6.4. Australia Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Competitive Insights
      • 9.6.7.4. Thailand Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.7. Latin America
    • 9.7.1. Latin America Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Regulatory Framework
      • 9.7.2.3. Competitive Insights
      • 9.7.2.4. Brazil Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Regulatory Framework
      • 9.7.3.3. Competitive Insights
      • 9.7.3.4. Argentina Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 9.8. MEA
    • 9.8.1. MEA Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Regulatory Framework
      • 9.8.2.3. Competitive Insights
      • 9.8.2.4. South Africa Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Regulatory Framework
      • 9.8.3.3. Competitive Insights
      • 9.8.3.4. Saudi Arabia Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Regulatory Framework
      • 9.8.4.3. Competitive Insights
      • 9.8.4.4. UAE Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Regulatory Framework
      • 9.8.5.3. Competitive Insights
      • 9.8.5.4. Kuwait Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 10. Medical Device Validation and Verification Market: Regional Estimates & Trend Analysis by Implants

  • 10.1. Regional Market Share Analysis, 2024 & 2030
  • 10.2. Regional Market Dashboard
  • 10.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 10.4. North America
    • 10.4.1. North America Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 10.4.2. U.S.
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Regulatory Framework
      • 10.4.2.3. Competitive Insights
      • 10.4.2.4. U.S. Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.4.3. Canada
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Regulatory Framework
      • 10.4.3.3. Competitive Insights
      • 10.4.3.4. Canada Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.4.4. Mexico
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Regulatory Framework
      • 10.4.4.3. Competitive Insights
      • 10.4.4.4. Mexico Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 10.5. Europe
    • 10.5.1. Europe Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 10.5.2. UK
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Regulatory Framework
      • 10.5.2.3. Competitive Insights
      • 10.5.2.4. UK Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.5.3. Germany
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Regulatory Framework
      • 10.5.3.3. Competitive Insights
      • 10.5.3.4. Germany Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.5.4. France
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Regulatory Framework
      • 10.5.4.3. Competitive Insights
      • 10.5.4.4. France Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.5.5. Italy
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Regulatory Framework
      • 10.5.5.3. Competitive Insights
      • 10.5.5.4. Italy Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.5.6. Spain
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Regulatory Framework
      • 10.5.6.3. Competitive Insights
      • 10.5.6.4. Spain Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.5.7. Norway
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Regulatory Framework
      • 10.5.7.3. Competitive Insights
      • 10.5.7.4. Norway Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.5.8. Denmark
      • 10.5.8.1. Key Country Dynamics
      • 10.5.8.2. Regulatory Framework
      • 10.5.8.3. Competitive Insights
      • 10.5.8.4. Denmark Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.5.9. Sweden
      • 10.5.9.1. Key Country Dynamics
      • 10.5.9.2. Regulatory Framework
      • 10.5.9.3. Competitive Insights
      • 10.5.9.4. Sweden Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 10.6. Asia Pacific
    • 10.6.1. Asia Pacific Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.6.2. Japan
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Regulatory Framework
      • 10.6.2.3. Competitive Insights
      • 10.6.2.4. Japan Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.6.3. China
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Regulatory Framework
      • 10.6.3.3. Competitive Insights
      • 10.6.3.4. China Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.6.4. India
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Regulatory Framework
      • 10.6.4.3. Competitive Insights
      • 10.6.4.4. India Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.6.5. South Korea
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Regulatory Framework
      • 10.6.5.3. Competitive Insights
      • 10.6.5.4. South Korea Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.6.6. Australia
      • 10.6.6.1. Key Country Dynamics
      • 10.6.6.2. Regulatory Framework
      • 10.6.6.3. Competitive Insights
      • 10.6.6.4. Australia Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.6.7. Thailand
      • 10.6.7.1. Key Country Dynamics
      • 10.6.7.2. Regulatory Framework
      • 10.6.7.3. Competitive Insights
      • 10.6.7.4. Thailand Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 10.7. Latin America
    • 10.7.1. Latin America Medical Device Validation and Verification Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 10.7.2. Brazil
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Regulatory Framework
      • 10.7.2.3. Competitive Insights
      • 10.7.2.4. Brazil Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 10.7.3. Argentina
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Regulatory Framework
      • 10.7.3.3. Competitive Insights
      • 10.7.3.4. Argentina Medical Device Validation and Verification Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦